It begins the selection of candidates to carry out a doctoral program in Regenerative Medicine between the SZBL and the IDIBELL. The program will run mainly at SZBL and will have a minimum six months stay at IDIBELL.
SZBL and IDIBELL launch their joint PhD Exchange Program call for 2022, with the aim of fostering collaboration in research between both institutions in the field of Regenerative Medicine and providing exceptional training in the field for graduated students by promoting mobility and allowing interaction with outstanding researchers.
A research team from IDIBELL, CRG and UB has uncovered the role of a gene that is critical to boosting the number of insulin-producing cells during the early development of the pancreas. The findings could bolster diabetes research efforts and eventually lead to new replacement therapies for the disease.